Andrew R. Robbins

Insider Reports History

Location
Boulder, CO
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew R. Robbins:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. President and CEO, Director Stock Option (Right to Buy) 915K Jan 23, 2025 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 Mar 11, 2024 Direct

Insider Reports Filed by Andrew R. Robbins

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jan 23, 2025 1 $0 4 Jan 27, 2025 President and CEO, Director
HARP Harpoon Therapeutics, Inc. Mar 11, 2024 3 $0 4 Mar 11, 2024 Director
COGT Cogent Biosciences, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 President and CEO, Director
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
COGT Cogent Biosciences, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 President and CEO, Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
COGT Cogent Biosciences, Inc. Jan 25, 2022 1 $3.41M 4 Jan 27, 2022 President and CEO, Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 1 $0 4/A May 14, 2021 Director